Skip to main content
Log in

Dihydroartemisinin-piperaquine highly cost effective for malaria prevention during pregnancy in Kenya and Uganda

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Fernandes S, et al. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data. The Lancet Global Health 8: No. 12, Dec 2020. Available from: URL: https://doi.org/10.1016/S2214-109X(20)30369-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dihydroartemisinin-piperaquine highly cost effective for malaria prevention during pregnancy in Kenya and Uganda. PharmacoEcon Outcomes News 867, 11 (2020). https://doi.org/10.1007/s40274-020-7308-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7308-1

Navigation